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Abstract  
Aims To evaluate the impact of gestational diabetes mellitus (GDM) and maternal height on 
offspring birthweight. 
Methods This is an observational cohort study, encompassing 4 111 Finnish primiparous women 
from Vantaa city, Finland, with singleton deliveries between 2009-2015. Data were obtained from 
the Finnish Medical Birth Register. The study population was divided into five groups according to 
maternal height. Cut-offs for height levels were I ≤ 158 cm, II 159-163 cm, III 164-167 cm, IV 168-
172 cm, V ≥ 173 cm. The main outcome measure was offspring birthweight, expressed as Z-scores 
according to sex and gestational age. 
Results Independently, both maternal height and GDM increased offspring birthweight (p<0.001 
for height and GDM). When studying the interaction, a significant increase in offspring birthweight 
was noted only in extreme height categories; group I ≤ 158 cm (p = 0.011), group IV 168-172 cm (p 
= 0.010) and group V ≥ 173 cm (p < 0.001) and the impact was similar in both sexes. Maternal 
height had no impact on offspring ponderal index (p=0.20 for trend).   
Conclusions In extreme height categories, short and tall primiparous women with GDM are at risk 
for delivering larger offspring compared to women without GDM of similar height.  
 
Keywords birthweight, gestational diabetes mellitus, maternal height, offspring, primiparous, 
stature 
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1. Introduction 
Fetal growth is a complex and multifactorial process influenced by several factors including genetic 
factors, in utero environment, maternal metabolism, duration of pregnancy and neonatal sex [1,2]. 
Of pregnancy complications, hypertensive disorders and gestational diabetes mellitus (GDM) are 
the best known underlying factors affecting fetal growth [3-5]. Offspring birth size, especially when 
considered macrosomic, increases the risk for delivery complications such as prolonged labor, 
operative vaginal delivery, cesarean section and admission of the newborn to neonatal centers [6]. 
Furthermore, a non-optimal fetal growth environment has been shown to have long-term effects on 
cardiovascular and metabolic disturbances, partly through its impact on birth size [7]. Due to short- 
and long-term health consequences associated with body size at birth, it is of interest to study 
factors potentially influencing fetal growth. 
GDM is a common pregnancy complication and has long been defined as any kind of abnormal 
glucose metabolism with onset or first detection during pregnancy [8]. Recent definitions are more 
precise in differentiating between pre-existing diabetes mellitus and GDM, depending on either 
different diagnostic criteria using 2-h 75-g oral glucose tolerance test (OGTT) or timing of 
diagnosis during pregnancy [9-11]. The prevalence of GDM varies between 2% to 32% with a 9% 
median estimate for North America and 6% for Europe [12]. GDM is known to increase the risk of 
macrosomia and metabolic disturbances for both mother and child later in life [13-16].  
Maternal anthropometry and its effects on fetal growth have been widely studied. Pre-pregnancy 
body mass index (BMI) has a direct effect on offspring birthweight and obesity increases the risk of 
macrosomia [17]. It has also been shown that GDM augments the effects of maternal BMI on 
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offspring birthweight when combined [5,18,19]. Maternal stature has been shown to be positively 
associated with newborn size at birth [20-22].  
Glucose metabolism itself is also affected by anthropometry. In non-pregnant, non-diabetic 
individuals it has been shown that taller people with a BMI below 35 kg/m
2 
tend to have lower 
postprandial glucose levels compared to shorter people with the same BMI, using standard 2-h 75-g 
OGTT, with no difference in fasting glucose levels [23]. It has also been shown that short stature in 
pregnant women is associated with elevated postprandial glucose levels with no difference in 
fasting glucose levels [24,25].   
In 2016, we initiated a long-term follow-up cohort study in the city of Vantaa, Finland, to assess 
both short- and long-term consequences of disturbances in glucose regulation on women’s and their 
offspring’s health. Since it has been shown that stature in pregnant women affects offspring size at 
birth and alters glucose metabolism, the aim of this study is to simultaneously study the impact of 
maternal height and GDM on offspring birthweight. 
 
2. Materials and Methods 
2.1. Subjects 
This study is an observational cohort study in the city of Vantaa, the fourth biggest city in Finland. 
Between January 1
st
 2009 and December 31
st
 2015, 7 750 primiparous women without a history of 
previously diagnosed diabetes mellitus gave birth. Of those, 4 111 women with Finnish background 
(born in Finland with Finnish or Swedish as mother tongue) and aged ≥ 18 years gave birth to a 
singleton offspring between gestational weeks 37 and 42 and had complete height and weight data 
together with complete data from a standard 2-h 75-g OGTT. The Finnish Current Care Guidelines 
for GDM recommends screening of all pregnant women during their first pregnancy for GDM using 
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2-h 75-g OGTT, except in low-risk patients, i.e. women aged under 25 years, with a BMI between 
18.5- 25 kg/m
2
 and with no family history of diabetes [26].  
Data on maternal-fetal characteristics and pregnancy outcomes were obtained from the Medical 
Birth Register, which is administrated by the National Institute for Health and Welfare in Finland 
and receives the information from all Finnish maternity hospitals. The following information on the 
primiparous women was obtained from this source: pre-gestational weight, height, previous 
pregnancies (miscarriages, induced abortions or ectopic pregnancies) and deliveries, infertility 
treatment, smoking during pregnancy, and hospitalization due to hypertension during pregnancy 
[27]. The following information on the offspring was collected: sex, birth length, birthweight, and 
head circumference.  
GDM was defined according to the Finnish Current Care Guidelines for GDM as one or more 
pathological glucose values in a standard 2-h 75-g OGTT [26]. The diagnostic thresholds were: 
fasting plasma glucose ≥ 5.3 mmol/L, 1-h glucose ≥ 10.0 mmol/L, and 2-h glucose ≥ 8.6 mmol/L 
[26].  
Macrosomia was defined as offspring birthweight ≥ 4 500g. Large for gestational age (LGA) and 
small for gestational age (SGA) were defined as a birthweight > 90
th
 percentile and <10
th
 percentile, 
respectively, according to gestational age and sex. Ponderal index (PI), was calculated for 
estimating body proportionality at birth and was defined as birth weight (kg) divided by birth length 
(m) in third power: PI = kg/m
3
 [28].
 
  
Educational attainment was defined according to years of schooling, as obtained from Statistics 
Finland [29].  
2.2. Statistical analysis  
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Data are presented as means with range or standard deviations (SD) or as counts with percentages. 
Standardized values were divided into five height level categories using z-scores: I (< -1.5), II (-1.5 
to < -0.319), III (-0.319 to < 0.319), IV (0.319 to < 1.15), and V (≥ 1.15) corresponding to grades 
containing 12.5, 25, 25, 25, and 12.5% of the total distribution. Cut-offs for maternal height levels 
were I ≤ 158 cm, II 159-163 cm, III 164-167 cm, IV 168-172 cm, V ≥ 173 cm.  Offspring 
birthweight and PI were calculated as Z-scores (according to sex and gestational age). Statistical 
significances for the unadjusted hypothesis of linearity across categories of height levels were 
evaluated by using the Cochran-Armitage test for trend and analysis of variance with an appropriate 
contrast. Adjusted hypothesis of linearity (orthogonal polynomial) was evaluated using generalized 
linear models (e.g. analysis of covariance and logistic models) with appropriate distribution and link 
function.  Models included age, education years and pre-pregnancy body mass as covariates. A 
possible nonlinear relationship between prevalence of GDM or offspring birthweight and the 
maternal standardized height was assessed by using 5-knot-restricted cubic spline regression. The 
length of the distribution of knots was located at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles 
corresponding to standardized height values of -1.66, -0.66, 0.01, 0.67 and 1.67. For restricted cubic 
splines, also known as natural splines, knot locations are based on Harrell's recommended 
percentiles or user-specified points [30]. The normality of the variables was tested by using the 
Shapiro–Wilk W test.  Statistical significance was set at p < 0.05. Stata 15.0 (StataCorp LP; College 
Station, Texas, USA) statistical package was used for the analysis. 
2.3. Ethical approval 
This study has been approved by the ethics committee of the Hospital District of Helsinki and 
Uusimaa (356/13/03/03/2015, November 2ⁿᵈ 2015), and by the health authority of Vantaa city, 
Finland. Permission to use register data for this study were given by the National Institute for 
Health and Welfare, and Statistics Finland. According to the ethics committee of Hospital District 
of Helsinki and Uusimaa, and the health authority of Vantaa city, the study participants do not need 
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to provide the Statement of Informed Consent, since this is an observational register-based study 
and the registered people were not contacted. 
 
3. Results 
3.1. Characteristics of the study participants 
Baseline characteristics of the 4 111 study participants divided into five height levels are shown in 
Table 1. The cut-offs were: I ≤ 158 cm, II 159-163 cm, III 164-167 cm, IV 168-172 cm, and V ≥ 
173 cm. Mean height of the study participants was 166.0 (SD 6.0) cm. Height was positively 
associated with age and educational attainment (both p < 0.001).  
Baseline characteristics of the offspring according to maternal height levels are shown in Table 2. 
Boys had a mean birthweight of 3 564 (SD 466) g, birth length 50.7 (SD 2.0) cm, and head 
circumference 35.3 (SD 1.4) cm, while the corresponding values for girls were 3 458 (SD 446) g, 
49.9 (SD 2.0) cm, and 34.8 (SD 1.4) cm, respectively. Maternal height was positively associated 
with offspring birthweight, birth length, and head circumference in both sexes, as well as with a 
higher prevalence of macrosomia and large for gestational age (LGA) newborns (all p < 0.001). In 
contrast, maternal height was inversely associated with small for gestational age (SGA) newborns 
(p < 0.001). Ponderal index of newborns did not differ across different maternal height levels. 
3.2. Maternal height and prevalence of gestational diabetes 
Figure 1 shows the prevalence of GDM at five different height levels and on a continuous scale 
with standardized height, adjusted for age and educational attainment. The prevalence of GDM was 
highest among the shortest women (≤ 158 cm) with a prevalence of 23.9% (95% CI 19.9- 27.9) and 
lowest in the group of average height women (164-167 cm) with a prevalence of 18.7% (95% CI 
  
9 
 
15.5- 21.9) (Figure 1B). There was an inverse relationship across maternal height levels and 
prevalence of GDM (p = 0.018 for linearity).  
3.3. Effect of maternal height and gestational diabetes on offspring birthweight and ponderal 
index 
Figure 2 shows the impact of maternal height and GDM and their interaction on offspring 
birthweight, adjusted for maternal age, pre-pregnancy BMI and educational attainment. In 
primiparous women without GDM, offspring birthweight increased with maternal height (p < 0.001 
for trend). Similarly, in primiparous women with GDM offspring birthweight increased with 
maternal height (p < 0.001 for trend), except in women of average height (159-167cm) which 
included about half of the study participants, in whom GDM had no significant influence on 
offspring birthweight. Maternal height had no impact on offspring PI (p=0.20 for trend, adjusted for 
maternal age, pre-pregnancy BMI and educational attainment) (Figure 3).  The impact of maternal 
height and GDM on offspring birthweight was similar for both sexes, as shown in Figure 4. 
 
4. Discussion 
According to the study findings in our cohort including Finnish women and their offspring, in 
primiparous women without GDM, offspring birthweight increased with maternal height. 
Interestingly, in primiparous women with GDM such an association with offspring birthweight was 
observed only in the extreme height categories of short and tall women, but not in women of 
average height. There was a significant interaction between maternal height and GDM on offspring 
birthweight, and the same trend was observed in both sexes. Tall primiparous women had an 
increased risk of newborn macrosomia and LGA newborns. Similarly, short stature was associated 
with SGA newborns. PI, in contrast, did not differ across different maternal height levels. 
Moreover, maternal height and GDM had no impact on PI.  
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The nationwide prevalence of GDM in Finland increased during our study period from 11.2% to 
15.9% in 2015 [27]. The high prevalence of GDM in our cohort is in line with nationwide findings.  
Overall, GDM prevalence can be considered high in Finland, when compared to a median estimate 
of 6% in Europe, even though GDM prevalence have been shown to vary between 2-32% globally 
[12]. The comprehensive screening for GDM since 2008 in Finland might possibly explain this 
rather high prevalence in our country and particularly in this study, in which only women with high-
risk for GDM with complete OGTT data were included.  
Our findings regarding maternal height and offspring birthweight in pregnancies without GDM 
were expected. Many other studies have shown a positive association between maternal height and 
offspring birth size [20-22,31]. Moreover, the positive association between maternal height and 
LGA babies, as well as the negative association between maternal height and SGA babies have 
been recognized previously. In fact,  a recent German study reported similar relationships [32]. 
Interestingly, neither maternal height nor GDM had any impact on PI. This might indicate that body 
proportionalities did not differ across different maternal height levels at term. 
The association between maternal height and offspring birth size has been thought to reflect mainly 
genetic factors [21], although the height of the mother and offspring body size, especially in 
developing countries, are also consequences of the nutritional status early in life [33]. Further, some 
physical aspects are thought to explain the correlation, including maternal constraint. In shorter 
mothers, there can be physical limitations for the growth of the uterus that can restrict fetal growth 
[34]. 
In most previous studies, a positive correlation between GDM and offspring birth size has been 
reported, but the effect of GDM on offspring birth size has been studied with no distinction of 
maternal stature [4,13,35]. In 1952, Jørgen Pedersen theorized that hyperglycemia of the mother led 
to hyperglycemia of the fetus and that this, in turn, amplified the fetal response to insulin [36]. 
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Pedersen´s hypothesis has formed the basic understanding of the pathophysiological consequences 
of diabetes during pregnancy. Modifying Pedersen´s hypothesis has led to the idea, that the impact 
of GDM on birth size is thought to be due to insulin resistance in diabetic mothers and an elevated 
glucose level that passes through the placenta.  This, in turn, increases the insulin levels of the fetus 
and leads to an excessive uptake of glucose, storage of glycogen and the formation of adipose 
tissue, resulting in macrosomia [13]. The Hyperglycemia and Adverse Pregnancy Outcomes 
(HAPO) study showed no threshold for glucose in relation to adverse pregnancy outcomes [4]. The 
results indicated a strong, positive and continuous association between increasing maternal glucose 
concentrations, already below those that are diagnostic for diabetes mellitus, and an increased 
birthweight [4].  
GDM is a heterogenic metabolic disorder and is thought to be caused by increasing insulin 
resistance due to placental hormonal influence and maternal adiposity in late pregnancy, impaired 
beta-cell function, genetic predisposition and in some cases autoimmunity [37]. Glucose 
metabolism has been shown to be affected by stature both in non-pregnant and pregnant individuals. 
In non-pregnant individuals, studies have shown that taller individuals tend to have lower 
postprandial glucose levels compared to shorter individuals using standard OGTT, with no 
difference in fasting glucose levels [23-25,38-40]. In line with our findings, previous studies have 
also proven GDM to be more common in shorter women [24-25,41], although some findings show 
no differences in stature between GDM and non-GDM women [42].  
It is not fully understood how stature influences glucose metabolism, but there are several 
hypotheses trying to explain the association. Taller people have more muscle mass, although not 
necessarily a higher percentage of muscle tissue in relation to total body mass. It is generally 
accepted that muscle tissue is the major tissue involved in glucose metabolism [39]. It has been 
theorized that the inverse association between height and postprandial glucose levels after a 
standard 2-h OGTT reflects the larger amount of metabolically active muscle tissue that taller 
  
12 
 
individuals, compared to shorter individuals, have to metabolize the same fixed load of glucose 
[39]. Height has also been positively associated with both pancreatic beta cell function and insulin 
sensitivity [38], possibly indicating a more favorable glucose regulation in tall, compared to short 
individuals. 
 
According to our findings, the simultaneous effect of maternal height and GDM affects offspring 
birthweight only in the extreme height categories of short and tall women. In Finland, GDM is 
diagnosed using a fixed load of 75-g glucose in association with a 2-h OGTT, regardless of 
maternal height, weight or body composition. The varying effect of GDM on offspring birthweight 
observed in different maternal height levels can probably partly be explained by differences in 
maternal anthropometrics including body composition. Perhaps, taller women with GDM might 
have a more severe degree of impairment in their glucose regulation compared to shorter women, 
consequently more often leading to macrosomia among the offspring. Among short women, it is 
possible that the muscle mass is limited – both quantitatively and qualitatively - and thus already a 
mild elevation in glucose concentration is more likely to affect the fetus.  
One can also speculate about possible effects of assortative mating on stature and paternal genetic 
imprinting on traits and disease burden in the fetus. According to a meta-analysis about assortative 
mating for human heights there is a moderate positive trend for assortative mating for height despite 
ethnicities, although, height cannot be considered as a major factor when choosing a partner [43]. 
Similarly, it is important to knowledge the possible impact of a short mothers’ own early growth 
and nutritional status. Birth size is known to be positively associated with adult height [44], in other 
words might short individuals have had a low birthweight and a non-optimal prenatal growth. There 
are several studies indicating that intrauterine growth restriction and malnutrition in infancy can 
lead to impaired glucose regulation and impaired endogenous pancreatic function in adulthood, 
predisposing to type 2 diabetes [45,46].  
  
13 
 
The question remains why offspring birthweight is not affected by GDM in women of average 
height? Interestingly, a recent Australian study shows no elevation at macrosomia rates in diet-
treated GDM women compared to non-diabetic controls, suggesting that a milder and diet-treated 
GDM could have a lower impact on risk of macrosomia [47]. Possibly, GDM is milder in women of 
average height where the influence of stature on glucose metabolism would be less. 
To the best of our knowledge, this is the first study to investigate the simultaneous effect of 
maternal height and GDM on offspring birthweight. According to our study findings, GDM 
increased offspring birthweight only in women with short or tall stature, while among the majority 
of women of average height no impact of GDM on birth size was observed. In clinical practice, this 
might indicate that both short and tall primiparous women with GDM should have a more intense 
follow up during pregnancy, and if needed, a customized plan for delivery. This area needs to be 
further explored, also taking into account the mother´s own birthweight and potential 
transgenerational aspects.  
The strength of this study is that the study cohort encompasses all adult Finnish primiparous women 
from the city of Vantaa, the fourth largest city in Finland, who gave birth to a singleton infant at 
term during a seven-year follow-up. The diagnosis of GDM is based on a 2-h 75-g oral glucose 
tolerance test and is considered reliable while it is standardized nationwide, and the diagnostic 
criteria have been the same during the follow-up period.  
The study has some limitations. We had no information on measures of insulin resistance, 
gestational weight gain, family history of diabetes, physical activity nor dietary habits. We also 
missed data on paternal anthropometry. Body composition and birthweight of the mothers´ were 
unknown. In this cohort all study participants were Finnish, therefore the generalization of our 
results globally can be limited. Noteworthy is that even if all women included in the study had a 
reliable GDM diagnosis based upon OGTT results, we have no other information on metabolic 
parameters and associations between these and offspring birthweight were unknown. 
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In conclusion, short and tall Finnish primiparous women with GDM are at risk of delivering larger 
infants compared to women without GDM with the same height. GDM does not affect offspring 
birthweight in Finnish primiparous women of average height. Among tall Finnish women with 
GDM, the prevalence of macrosomia is increased. Maternal height had no impact on offspring PI. 
To minimize the adverse effects of an increased birthweight and/or macrosomia, special attention 
should be paid to women with GDM, especially in the subgroups of short and tall women.  
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Table 1 
Baseline characteristics of the 4 111 primiparous women according to height levels 
 Height levels                                 
Characteristics of the  
women 
I 
N=442 
II 
N=990 
III 
N=974 
IV 
N=1132 
V 
N=573 
p-value for 
linearity 
 
Height (cm), mean (range) 
 
156 (137- 158) 
 
161 (159-163) 
 
165 (164- 167) 
 
170 (168- 172) 
 
176 (173- 190) 
 
Age (years), mean (SD) 28.7 (4.7) 29.3 (4.8) 29.6 (4.8) 29.6 (4.8) 30.1 (4.6) < 0.001 
Cohabiting, n (%) 352 (80) 802 (81) 803 (82) 936 (83) 489 (85) 0.012 
Smokers
 a
, n (%) 79 (18) 158 (16) 141 (14) 174 (15) 79 (14) 0.10 
Years of education, mean (SD) 13.5 (2.5) 13.8 (2.5) 13.8 (2.4) 13.9 (2.5) 14.2 (2.5) < 0.001 
Prepregnancy BMI (kg/m
2
), mean (SD) 24.9 (4.7) 24.6 (4.3) 24.8 (4.6) 24.9 (5.0) 24.7 (5.0) 0.93 
Previous pregnancies, n (%) 93 (21) 202 (20) 189 (19) 245 (22) 89 (16) 0.15 
Fertility treatment, n (%) 34 (8) 92 (9) 94 (10) 122 (11) 60 (10) 0.068 
Hypertensive disorders
 b
, n (%) 31 (7) 54 (5) 73 (7) 79 (7) 31 (5) 0.94 
BMI, body mass index; SD, standard deviation 
a
 Included those who quitted smoking during pregnancy;
 b 
Hospitalization due to hypertension during pregnancy  
Statistical significances for the unadjusted hypothesis of linearity across categories of height levels were evaluated by using the Cochran-Armitage test for trend 
and analysis of variance.
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Table 2 
Baseline characteristics of the 4 111 offspring according to maternal height 
a 
 Height levels 
 
 
Characteristics of the 
 
offspring 
I 
 
N=442 
II 
 
N=990 
III 
 
N=974 
IV 
 
N=1132 
V 
 
N=573 
 
p-value for 
linearity 
 
Boys, n (%) 
 
238 (54) 
 
516 (52) 
 
527 (54) 
 
572 (51) 
 
298 (52) 
 
0.37 
 
Birthweight (g), mean (SD) 
      
     
   Boys 
 
3 435 (451) 
 
3 483 (443) 
 
3 529 (478) 
 
3 653 (461) 
 
3 700 (445) 
 
< 0.001 
     
   Girls 
 
3 304 (441) 
 
3 406 (415) 
 
3 466 (448) 
 
3 511 (465) 
 
3 539 (423) 
 
< 0.001 
 
Birth length (cm), mean (SD) 
      
 
   Boys 
 
50.0 (2.0) 
 
50.3 (1.9) 
 
50.5 (1.9) 
 
51.0 (2.0) 
 
51.3 (1.9) 
 
< 0.001 
     
   Girls 
 
49.1 (2.0) 
 
49.7 (1.9) 
 
49.8 (1.9) 
 
50.1 (2.0) 
 
50.4 (1.9) 
 
< 0.001 
 
Birth weight (Z-score), mean (SD) 
      
 
   Boys 
 
-0.31 (0.94) 
 
-0.18 (0.95) 
 
-0.07 (1.00) 
 
0.19 (0.99) 
 
0.33 (0.99) 
 
< 0.001 
     
   Girls 
 
-0.37 (0.94) 
 
-0.17 (0.91) 
 
0.04 (1.01) 
 
0.15 (1.02) 
 
0.19 (1.01) 
 
< 0.001 
 
Ponderal Index, (weight [kg]/ height 
[m]
3
), mean (SD) 
      
 
   Boys 
 
27.4 (2.6) 
 
27.2 (2.4) 
 
27.3 (2.5) 
 
27.5 (2.4) 
 
27.4 (2.5) 
 
0.42 
     
   Girls 
 
27.4 (2.6) 
 
27.8 (2.3) 
 
27.9 (2.5) 
 
27.9 (2.5) 
 
27.7 (2.5) 
 
0.76 
 
Head circumference (cm), mean (SD) 
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   Boys 
 
35.0 (1.5) 
 
35.1 (1.4) 
 
35.3 (1.5) 
 
35.5 (1.4) 
 
35.6 (1.4) 
 
< 0.001 
     
   Girls 
 
34.3 (1.5) 
 
34.7 (1.3) 
 
34.8 (1.4) 
 
35.0 (1.4) 
 
35.0 (1.3) 
 
< 0.001 
 
Macrosomia (birthweight ≥ 4500g), n (%) 
 
LGA (>90h percentile), n (%) 
 
2 (0.5) 
 
22 (5.0) 
 
12 (1.2) 
 
66 (6.7) 
 
23 (2.4) 
 
100 (10.3) 
 
37 (3.2) 
 
148 (13.1) 
 
20 (3.5) 
 
75 (13.1) 
 
< 0.001 
 
< 0.001 
 
SGA (<10h percentile), n (%) 
 
69 (15.6) 
 
122 (12.3) 
 
107 (11.0) 
 
78 (6.9) 
 
34 (5.9) 
 
< 0.001 
SD, standard deviation;  
a
Cut-offs for the different height levels were I ≤ 158 cm, II 159 – 163 cm, III 164 – 167 cm, IV 168 – 172 cm, and V ≥ 173 cm. 
Statistical significances for the unadjusted hypothesis of linearity across categories of height levels were evaluated using Cochran-Armitage test for trend and 
analysis of variance
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Figure 1 
Prevalence of GDM according to height of the women 
 
 
 
 
(A) Prevalence of GDM at five different height levels, with cut-offs for height levels at I ≤ 158 
cm, II 159 – 163 cm, III 164 – 167 cm, IV 168 – 172 cm, and V ≥ 173 cm. Whiskers show 95% 
confidence intervals. (B) Prevalence of GDM on a continuous scale with standardized maternal 
height. The curve was derived from a 5-knot restricted cubic splines regression model and gray 
area represent 95% confidence interval. Both figures were adjusted for age and educational 
attainment.  
GDM, gestational diabetes 
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Figure 2 
Impact of maternal height and GDM on offspring birthweight 
 
 
 
The impact of maternal height and GDM and their interaction on offspring birthweight in five 
different height levels (A) and as a continuum (B) with standardized maternal height adjusted for 
age, pre-pregnancy body mass index and educational attainment. Cut-offs for maternal height 
levels were I ≤ 158 cm, II 159-163 cm, III 164-167 cm, IV 168-172 cm, V ≥ 173 cm.  Offspring 
birthweight was calculated as Z-scores (according to sex and gestational age).  
GDM, Gestational diabetes mellitus 
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Figure 3 
Impact of maternal height and GDM on offspring Ponderal Index 
 
 
The impact of maternal height and GDM and their interaction on offspring Ponderal Index in 
five different height levels (A) and as a continuum (B) with standardized maternal height 
adjusted for age, pre-pregnancy body mass index and educational attainment. Cut-offs for 
maternal height levels were I ≤ 158 cm, II 159-163 cm, III 164-167 cm, IV 168-172 cm, V ≥ 173 
cm.  Offspring Ponderal Index was calculated as Z-scores (according to sex and gestational age).  
GDM, Gestational diabetes mellitus 
PI, Ponderal Index 
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Figure 4                                                                                                                                        
Impact of maternal height and GDM on offspring birthweight in girls and boys  
 
The impact of maternal height and GDM and their interaction on offspring birthweight in both 
girls (A) and boys (B) in five different height levels (age, pre-pregnancy body mass index and 
educational attainment adjusted). Cut-offs for height were I ≤ 158 cm, II 159-163 cm, III 164-
167 cm, IV 168-172 cm, V ≥ 173 cm.  Offspring birthweight was calculated as Z-scores 
(according to sex and gestational age).  
GDM, Gestational diabetes mellitus 
